Summary

The global veterinary vaccines market size reached USD 14.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 29.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.71% during 2025-2033. The market is driven primarily because of the growing focus on veterinary healthcare, need for livestock insurance and the launch of new veterinary vaccinations. At present, North America dominates the market because of the rising number of pet parents, advanced veterinary healthcare infrastructure, and significant livestock industry.

Veterinary vaccines represent bio-prepared immunizations that are administered to domestic animals or wild species through parenteral and oral routes to stimulate protective immune responses without causing the disease itself. They involve inactivated, live attenuated and recombinant vaccines as some common medications. These inoculations aid in reducing animal suffering, enhancing immune efficiency, and preventing the risk of developing and transmitting various contagious zoonotic diseases.

Veterinary Vaccines Market Trends:

Growing focus on veterinary healthcare
According to the IMARC Group’s report, the global veterinary healthcare market reached USD 43.3 Billion in 2023. As more individuals are becoming pet parents, there is a greater emphasis on their well-being, resulting in increased veterinary appointments and preventive treatment. Vaccinations are an important aspect of keeping pets healthy, which is driving the demand for veterinary vaccinations. The growing awareness among the masses about the necessity of preventing animal diseases rather than simply treating them is offering a favorable veterinary vaccines market outlook. Vaccination is a very efficient preventive measure, making it an essential component of veterinary healthcare regimens for both companion animals and cattle. Pet parents and livestock producers are willing to pay more on healthcare, including vaccines, to prevent diseases that could harm animal health and productivity. This tendency is catalyzing the demand for a wide variety of immunizations, particularly as veterinary services become more accessible.

Increasing demand for livestock insurance
The IMARC Group’s report shows that the global livestock insurance market reached USD 3.6 Billion in 2023. Many livestock insurance policies demand vaccinations against common diseases as a condition of coverage. Insured farmers and livestock owners are incentivized to vaccinate their animals to meet policy obligations, which is positively influencing the veterinary vaccines market share. Livestock insurance is generally used to reduce the financial risks connected with livestock loss caused by disease, accidents, or natural catastrophes. Farmers who vaccinate their animals lessen the chance of disease outbreaks, making their livestock more insurable and lowering the possibility of claims. This encourages regular vaccinations, which increases vaccine demand.

New launches
New veterinary vaccinations are being produced to combat developing diseases and newly discovered pathogens impacting animals. As outbreaks of previously unknown or developing illnesses are arising, the demand for novel vaccines is rising, thereby propelling veterinary vaccines market growth. Next-generation vaccines, such as recombinant, DNA, and vector-based vaccinations, improve the efficacy and safety of disease prevention in animals. These new vaccines are frequently more effective, have fewer side effects, and give longer-lasting protection, making them more appealing to physicians and pet owners. New releases frequently feature vaccines that cover many diseases or strains in a single shot, making life easier for vets and owners.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global market, along with veterinary vaccines market forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on vaccine type, technology, route of administration and distribution channel.

Breakup by Vaccine Type:
? Livestock Vaccines
o Bovine Vaccines
o Poultry Vaccines
o Porcine Vaccines
o Others
? Companion Animal Vaccines
o Canine Vaccines
o Feline Vaccines
o Equine Vaccines

Breakup by Technology:
? Attenuated Live Vaccines
? Inactivated Vaccines
? Toxoid Vaccines
? Recombinant Vaccines
? Others

Breakup by Route of Administration:
? Subcutaneous
? Intramuscular
? Intranasal

Breakup by Distribution Channel:
? Veterinary Hospitals
? Veterinary Clinics
? Pharmacies and Drug Stores
? Others

Breakup by Region:
? North America
o United States
o Canada
? Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
? Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
? Latin America
o Brazil
o Mexico
o Others
? Middle East and Africa

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global veterinary vaccines market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:
? Boehringer Ingelheim International GmbH
? Ceva Sant? Animale
? Elanco Animal Health Incorporated
? Hester Biosciences Limited
? HIPRA
? Indian Immunologicals Limited
? Merck & Co. Inc.
? Neogen Corporation
? Phibro Animal Health Corporation
? Virbac SA
? Zoetis Inc.


Key Questions Answered in This Report:
? How has the global veterinary vaccines market performed so far and how will it perform in the coming years?
? What has been the impact of COVID-19 on the global veterinary vaccines market?
? What are the key regional markets?
? What is the breakup of the market based on the vaccine type?
? What is the breakup of the market based on the technology?
? What is the breakup of the market based on the route of administration?
? What is the breakup of the market based on the distribution channel?
? What are the various stages in the value chain of the industry?
? What are the key driving factors and challenges in the industry?
? What is the structure of the global veterinary vaccines market and who are the key players?
? What is the degree of competition in the industry?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Veterinary Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Vaccine Type
6.1 Livestock Vaccines
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Bovine Vaccines
6.1.2.2 Poultry Vaccines
6.1.2.3 Porcine Vaccines
6.1.2.4 Others
6.1.3 Market Forecast
6.2 Companion Animal Vaccines
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Canine Vaccines
6.2.2.2 Feline Vaccines
6.2.2.3 Equine Vaccines
6.2.3 Market Forecast
7 Market Breakup by Technology
7.1 Attenuated Live Vaccines
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Inactivated Vaccines
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Toxoid Vaccines
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Recombinant Vaccines
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Subcutaneous
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Intramuscular
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Intranasal
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Veterinary Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Veterinary Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmacies and Drug Stores
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Boehringer Ingelheim International GmbH
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Ceva Sant? Animale
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Elanco Animal Health Incorporated
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Hester Biosciences Limited
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 HIPRA
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Indian Immunologicals Limited
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Merck & Co. Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Neogen Corporation
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Phibro Animal Health Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Virbac SA
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.11 Zoetis Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials

ページTOPに戻る

List of Tables/Graphs

List of Figures

?Figure 1: Global: Veterinary Vaccines Market: Major Drivers and Challenges
Figure 2: Global: Veterinary Vaccines Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Veterinary Vaccines Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Veterinary Vaccines Market: Breakup by Vaccine Type (in %), 2024
Figure 5: Global: Veterinary Vaccines Market: Breakup by Technology (in %), 2024
Figure 6: Global: Veterinary Vaccines Market: Breakup by Route of Administration (in %), 2024
Figure 7: Global: Veterinary Vaccines Market: Breakup by Distribution Channel (in %), 2024
Figure 8: Global: Veterinary Vaccines Market: Breakup by Region (in %), 2024
Figure 9: Global: Veterinary Vaccines (Livestock Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Veterinary Vaccines (Livestock Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Veterinary Vaccines (Companion Animal Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Veterinary Vaccines (Companion Animal Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Veterinary Vaccines (Attenuated Live Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Veterinary Vaccines (Inactivated Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Veterinary Vaccines (Inactivated Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Veterinary Vaccines (Toxoid Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Veterinary Vaccines (Toxoid Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Veterinary Vaccines (Recombinant Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Veterinary Vaccines (Recombinant Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Veterinary Vaccines (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Veterinary Vaccines (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Veterinary Vaccines (Subcutaneous) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Veterinary Vaccines (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Veterinary Vaccines (Intramuscular) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Veterinary Vaccines (Intramuscular) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Veterinary Vaccines (Intranasal) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Veterinary Vaccines (Intranasal) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Veterinary Vaccines (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Veterinary Vaccines (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Veterinary Vaccines (Veterinary Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Veterinary Vaccines (Veterinary Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Veterinary Vaccines (Pharmacies and Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Veterinary Vaccines (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Veterinary Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: North America: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: North America: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: United States: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: United States: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Canada: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Canada: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Asia-Pacific: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Asia-Pacific: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: China: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: China: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Japan: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Japan: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: India: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: India: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: South Korea: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: South Korea: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Australia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Australia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Indonesia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Indonesia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Europe: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Europe: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Germany: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Germany: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: France: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: France: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: United Kingdom: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: United Kingdom: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Italy: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Italy: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Spain: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Spain: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Russia: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Russia: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Latin America: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Latin America: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Brazil: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Brazil: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Mexico: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Mexico: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Others: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Others: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Middle East and Africa: Veterinary Vaccines Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Middle East and Africa: Veterinary Vaccines Market: Breakup by Country (in %), 2024
Figure 85: Middle East and Africa: Veterinary Vaccines Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Global: Veterinary Vaccines Industry: SWOT Analysis
Figure 87: Global: Veterinary Vaccines Industry: Value Chain Analysis
Figure 88: Global: Veterinary Vaccines Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Veterinary Vaccines Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Veterinary Vaccines Market Forecast: Breakup by Vaccine Type (in Million USD), 2025-2033
Table 3: Global: Veterinary Vaccines Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 4: Global: Veterinary Vaccines Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 5: Global: Veterinary Vaccines Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 6: Global: Veterinary Vaccines Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Veterinary Vaccines Market: Competitive Structure
Table 8: Global: Veterinary Vaccines Market: Key Players